Gemelli TracerGlab

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gemelli Science Technology Park (G-STeP)
Università Cattolica del Sacro Cuore
Medipass Ergea

Il Gemelli protagonista della Ricerca Internazionale: a un anno dall’inaugurazione, la facility G-STEP Radiopharmacy, coordinata dal dottor Annunziata, è attiva su quattro importanti progetti in grado di svelare patologie tumorali e non, focalizzati anche su depressione e diabete.

Lo studio dei nuovi radiofarmaci e della teranostica nucleare, è fra i settori più in crescita e il Policlinico è al centro di questo grande fermento.
“Questa è una sfida che vogliamo cogliere nell’ambito del nuovo Dipartimento, attraverso il coordinamento dipartimentale delle facility di GSTeP Bio-Image Analysis Centre” commenta la prof.ssa Sala.

“A un anno dall’inaugurazione - conclude il professor Scambia - la ricerca sui radiofarmaci sperimentali attraverso GSTeP Radiopharmacy si propone di mettere il Gemelli all’avanguardia, in Italia e in ambito internazionale, nel campo della medicina personalizzata e di precisione”.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
Gemelli Science Technology Park (GSTeP)
Medipass Ergea

Radiofarmaci Sperimentali: il Gemelli protagonista della ricerca internazionale - Policlinico Universitario A. Gemelli IRCCS 4 progetti di ricerca nella facility G-STEP Radiopharmacy in grado di svelare patologie tumorali e non tumorali A un anno dall’inaugurazione, presso la facility G-STEP Radiopharmacy, coordinata dal dottor Salvatore Annunziata, ferve l’attività di ricerca su nuovi radiofarmaci sperimentali in gr...

Celebrating full of our for of , and .

Happy to support of the smartest in the next months.






Gemelli Science and Technology Park (G-STeP)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
Ergea Medipass

, and .

Great in , with several , and , for and of .

See you next year!






Gemelli Science and Technology Park (G-STeP)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
EANM

are crucial in current .

At GSTeP Radiopharmacy - TracerGLab different with connections work to support on and .

Happy to all!






Gemelli Science and Technology Park (G-STeP)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
Medipass Ergea

In 2023, our is studying possible and of new , including but not limited to 11C-PiB, 18F-MC225 and 68Ga-CXCR4, with different and .

Eight approved are already in production for , including 18F/68Ga-PSMA.

Thank you for your efforts!

Gemelli Science and Technology Park (G-STeP)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Medipass - Advanced Medical Services

Daniele Pizzuto is a Physician with a brilliant curriculum and a large international on hybrid in pelvic .

He is now of one of the most prestigious in , 2023.

At GSTeP Radiopharmacy - TracerGLab, Daniele will evaluate in , to possibly address personalised treatments.

https://lnkd.in/d2YEU_7S

Gemelli Science and Technology Park (G-STeP)
Radiomics GSTeP core research facility
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
Fondazione Umberto Veronesi

Daniele Antonio Pizzuto | Fondazione Umberto Veronesi La tomografia a emissioni di positroni (PET) è un esame diagnostico molto utile nella cura del tumore prostatico: si somministra un “radiofarmaco” (cioè una molecola legata a un isotopo radioattivo che si aggancia alle cellule tumorali prostatiche) e si ottengono le immagini del tumore in 3D. ...

GSTeP Radiopharmacy - TracerGLab a and a to all of you.








Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gemelli Science and Technology Park (G-STeP)
Medipass - Advanced Medical Services

Radiofarmacia – Gemelli Science & Technology Park G STeP

and physicians became eligible for another large national Ricerca Finalizzata GR 2021, with an experimental protocol on glicoprotein-p 18F-MC225 in .

Glad to support PI Alessio Simonetti and his .







Gemelli Science and Technology Park (G-STeP)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Bando della ricerca finalizzata 2021, finanziati 261 progetti Sono 261 i progetti di ricerca ammessi al finanziamento per i complessivi 100 milioni di euro del Bando della ricerca finalizzata 2021

2022, the world leading on and , is approaching in (15-19 October 2022).

Let's meet in person again, in different sessions, committes and booths, to discuss partnerships on , , and .







Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Medipass - Advanced Medical Services
EANM

EANM 2022 Congress | October 15-19, 2022 Official Website of the EANM Congress 2022. Get all your information here. Abstract submission is now open!

A joint and model can predict poor interim response in , according to this new paper within .

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Ministero della Salute

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment (1) This study aimed to investigate whether baseline clinical and Positron Emission Tomography/Computed Tomography (bPET)-derived parameters could help predicting early response to the first two cycles of chemotherapy (Deauville Score at interim PET, DS at iPET) in patients with classical Hodgkin ly...

Happy to show two more in our team, powered with Medipass - Advanced Medical Services.

Mary Ruggiero is a with international experience on early-phase and on .

Chiara Franciosi is a , with large national experience as and on - .

New can trace microenvironment in , with possible further impact on .

Enjoy this systematic review promoted by Elizabeth K.A. Triumbari, with a .

Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review - PubMed Objective: Immuno-positron emission tomography (iPET) combines the sensitivity of the PET imaging technique and the targeting specificity of radio-labelled monoclonal antibodies (mAb). Its first clinical applications in humans were described in the late 1990s, and several pathologies ha...

Angela Collarino is a within Direzione Scientifica at Fondazione Policlinico Universitario Agostino Gemelli IRCCS and Gemelli TracerGlab.

She is involved in national and international networks on , with regard to , and new .

Follow us for next updates.




***a


Leids Universitair Medisch Centrum - LUMC

AIMN - Gruppi di Studio

Happy first Gemelli TracerGLab!

Celebrate ongoing , 2 new , 8 new , 10 institutional applied, 1 won, 20 contacts, several and accepted.

Thanks to Direzione Scientifica, Unit, Department of and , , Fondazione Policlinico Universitario Agostino Gemelli IRCCS and Medipass - Advanced Medical Services.

Salvatore Annunziata Angela Collarino
Elizabeth K.A. Triumbari David Morland
Roberta Visentin Chiara Franciosi
Marco De Summa Giulio Iachetti

could predict prognosis in , as an alternative to .

Enjoy this new , part of an by our visitor David Morland, within the pipeline of 2019.

Frontiers, Ministero della Salute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Salvatore Annunziata Elizabeth K.A. Triumbari
Annarosa Cuccaro Elena Maiolo Stefan Hohaus
Prof. Dr. Giorgio Treglia, MD MSc(HTA)

Healthy Organs Uptake on Baseline 18F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma PurposeHealthy organs uptake, including cerebellar and liver SUVs have been reported to be inversely correlated to total metabolic tumor volume (TMTV), a controversial predictor of event-free survival (EFS) in classical Hodgkin's Lymphoma (cHL). The objective of this study was to estimate TMTV by us...

Next week at Congress in !

Elizabeth K.A. Triumbari will show preliminary on and partnerships on new and .

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Ministero della Salute

Salvatore Annunziata David Morland
Angela Collarino Marco De Summa
Roberto Gatta Luca Boldrini
Annarosa Cuccaro Elena Maiolo
Stefan Hohaus

Gemelli TracerGLab is partecipating to the and GICR Congress 2022, where and developments in the Italian context will be evaluated.

We will be there to discuss further projects with , and .

AIMN - Corsi, Convegni e Congressi organizzati da AIMN

Glad to have two PET/CT scanners accredited by !

is necessary for , and new .

Thanks to Amedeo Capotosti and Marco De Summa.

First by Gemelli TracerGLab, dedicated exclusively to private !

About 30 partners heard on possible R&D on , , and by GSTeP Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Follow us for further information!

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Salvatore Annunziata Camilla Nero Roberto Gatta

Medipass - Advanced Medical Services
Roberta Visentin Guido Maria Meduri
Marco De Summa Sandro Spinosa Chiara Franciosi

in the !

Thanks to new facilities in Q2 2022, we can plan new radiolabeled with 18F, 11C, 68Ga and new solid as 68Ga, 64Cu and 89Zr in Q3-Q4 2022.

Happy Easter and good luck!







Salvatore Annunziata
Angela Collarino Elizabeth K.A. Triumbari David Morland
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roberta Visentin Chiara Franciosi Marco De Summa
Antonella Moretti Sandro Spinosa Giulio Iachetti
Medipass - Advanced Medical Services

approved the first commercial couple for metastatic .

Gemelli TracerGLab can now produce 18F-PSMA according to pharmacopeia, for both and aims, such as larger availability, and PSMA .

FDA approves Pluvicto for metastatic castration-resistant prostate can Oncology / Hematology Approvalls

Happy to show two new who joined Gemelli TracerGLab in February.

Elizabeth K.A. Triumbari is within the on , with international experience on new .

David Morland is MD, and , one-year on and .

Gemelli TracerGLab is the new born in and (GSTeP) at Fondazione Policlinico Universitario Agostino Gemelli IRCCS

For its purposes, Gemelli TracerGLab closely works with Direzione Scientifica, the of , and and the of , and with the support by Medipass Advanced Medical Service.

Gemelli Science e Parco Tecnologico | Policlinico Gemelli Roma I ricercatori del Policlinico Gemelli hanno accesso ad un’ampia gamma di core facilities di ricerca per ottimizzare e accelerare lo sviluppo dei loro progetti

In the , Gemelli TracerGLab celebrates the role of and against .

Salvatore Annunziata, MD, PhD is the Lab Head, won a national about and is planning new in several .

Angela Collarino MD, PhD works in Direzione Scientifica and cooperates with an on and in .

Gemelli TracerGLab is happy to support 8 different teams applying to the new national by Ministero della Salute, with several interesting projects about .
Good luck to all the !

Bando della ricerca finalizzata 2021: fondi per 100 milioni di euro Il Bando, le procedure e le modalità di partecipazione; 57 milioni di euro destinati ai giovani ricercatori

Gemelli TracerGlab a and a to all of you and your families!








Salvatore Annunziata, Angela Collarino
Antonella Moretti, Marco De Summa,
Chiara Franciosi, Sandro Spinosa
Giulio Iachetti

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Medipass Advanced Medical Services